Compare PKBK & QTRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PKBK | QTRX |
|---|---|---|
| Founded | 1999 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 314.7M | 306.0M |
| IPO Year | 2005 | 2017 |
| Metric | PKBK | QTRX |
|---|---|---|
| Price | $29.59 | $3.38 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $8.00 |
| AVG Volume (30 Days) | 92.5K | ★ 893.5K |
| Earning Date | 04-20-2026 | 05-11-2026 |
| Dividend Yield | ★ 2.43% | N/A |
| EPS Growth | ★ 39.21 | N/A |
| EPS | ★ 3.16 | N/A |
| Revenue | N/A | ★ $37,632,000.00 |
| Revenue This Year | N/A | $25.49 |
| Revenue Next Year | N/A | $9.82 |
| P/E Ratio | $9.37 | ★ N/A |
| Revenue Growth | N/A | ★ 64.52 |
| 52 Week Low | $17.16 | $3.24 |
| 52 Week High | $29.99 | $8.77 |
| Indicator | PKBK | QTRX |
|---|---|---|
| Relative Strength Index (RSI) | 70.45 | 28.94 |
| Support Level | $26.56 | N/A |
| Resistance Level | N/A | $3.90 |
| Average True Range (ATR) | 0.51 | 0.26 |
| MACD | 0.15 | 0.04 |
| Stochastic Oscillator | 80.24 | 14.01 |
Parke Bancorp Inc operates as a commercial bank providing personal and financial services to individuals and small to mid-sized businesses in various states of the USA. The bank offers services such as loan products, deposit services, and other financial products through its retail branches and other channels to its customers. Its lending businesses are commercial real estate lending, residential real estate lending, and construction lending among others. The Company operates one reportable segment of business, community banking.
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.